English EN Spanish ES French FR Chinese (Simplified) ZH-CN
Print Friendly, PDF & Email

NCT/Study#

NCT04164082 /

A031803

Phase II Trial Of Intravesical Gemcitabine And MK-3475 (Pembrolizumab) In The Treatment Of Patients With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

DISEASE GROUP:
Genito-Urinary
current phase:
Phase II
STUDY STATUS:
Active
Location:
Hackensack, NJ
For More information: